IPWatchdog.com | Patents & Intellectual Property LawJump Rope Company Asks High Court to Weigh in on CAFC Approach to Collateral Estoppel for PTAB Invalidations September 26, 2022The inventor of a novel jump rope system (the Revolution Rope), Molly Metz, is petitioning the U.S. Supreme Court through her company, Jump Rope Systems, LLC, to seek clarification of the collateral estoppel doctrine as applied by the U.S. Court of Appeals for the Federal Circuit (CAFC) to bar a patent infringement suit in district […] Eileen McDermottThis Week in Washington IP: Securing U.S. Leadership in Emerging Compute Technologies, Managing the Risks of AI, and Incorporating Commercial Drones Into U.S. Airspace September 26, 2022This week in Washington IP news, the Senate Aviation Safety Subcommittee takes a look at incorporating unmanned aerial systems more fully into the U.S. national airspace, while the full Senate Commerce Committee explores how to maintain U.S. leadership in emerging compute technologies. Over in the House of Representatives, the House Science Committee focuses on the […] Steve BrachmannTo Become Transaction-Ready, Startups Need IP Business Strategists September 26, 2022On the second day of the IPWatchdog LIVE conference held in Dallas, Texas, earlier this month, a panel of experts who advise startups and are passionate about the licensing business model discussed the challenges and opportunities presented by intellectual property. The panelists opened the discussion by describing their experiences with the biggest mistakes startups make […] Madeleine KeyReview Not Warranted: SG Tells SCOTUS to Scrap Amgen’s Case on Enablement Test for Biotech Patents September 25, 2022The United States Solicitor General (SG) on Wednesday accepted the U.S. Supreme Court’s invitation to file an amicus brief regarding Amgen’s petition for certiorari in its case against Sanofi. Amgen is seeking review of the U.S. Court of Appeals for the Federal Circuit’s (CAFC’s) decision invalidating antibody patent claims based on a lack of enablement […] Eileen McDermottAdvocating for Ethics-Driven Regulation for Blockchain Technologies September 24, 2022Blockchain technology can serve as a shared database ledger that tracks assets and transactions with little to no oversight but, in theory, unlimited users. Its potential applications spanning smart contracts to blockchaining intellectual property, indicate promise for fluid collaborations, efficient remuneration and thorough intellectual property management. However, there are still crucial issues, including privacy, compatibility, […] Monica JangOther Barks & Bites for Friday, September 23: Thaler Seeks Rehearing of CAFC Decision on DABUS AI, the Solicitor General Urges SCOTUS to Deny Cert in Amgen, and FTC Orders Amazon’s Jassy and Bezos to Testify in Prime Investigation September 23, 2022This week in Other Barks & Bites: the Journalism Protection and Competition Act moves out of the Senate Judiciary Committee with a content moderation amendment securing Republican support; the U.S. Solicitor General files a brief with the U.S. Supreme Court recommending denial of a petition for writ of certiorari in Amgen; the Federal Trade Commission […] Steve BrachmannPatent Filings Roundup: Western District Waters Tested; IP Edge Runs from Disclosure in Delaware September 23, 2022Twenty-three inter partes reviews (IPRs) and no post grant reviews were filed this week; plaintiffs filed an average-ish 79 new district court filings, though many were associated with older campaigns. The Daedalus Prime subsidiary asserting Intel patents has filed suits against Samsung and TSMC; Volkswagen filed a number of IPRs against Fortress-backed Neo Wireless. There […] Jonathan StroudExploring the CAFC’s Ridiculous Written Description Standard for Life Sciences Patents September 22, 2022The written description requirement is really the backbone of the quid pro quo between the public and the patent applicant. In exchange for information about an invention, society is willing to grant the applicant a patent, which conveys exclusive rights for a limited period of time to what is claimed, not described. But the description […] Gene Quinn
